Gensavis Pharmaceuticals, LLC   Report issue

For profit Phase 4
Founded: Corpus Christi TX United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2013
NCT01904864
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

ferrous sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Deficiency Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1